193 related articles for article (PubMed ID: 33710416)
1. Vascular calcification and response to neoadjuvant therapy in locally advanced rectal cancer: an exploratory study.
Knight KA; Drami I; McMillan DC; Horgan PG; Park JH; Jenkins JT; Roxburgh CSD
J Cancer Res Clin Oncol; 2021 Nov; 147(11):3409-3420. PubMed ID: 33710416
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of tumour regression grade after neoadjuvant chemoradiotherapy for a cohort of patients with locally advanced rectal cancer: an 8-year retrospective single-institutional study.
Xu L; Cai S; Xiao T; Chen Y; Qiu H; Wu B; Lin G; Sun X; Lu J; Zhou W; Xiao Y
Colorectal Dis; 2017 Jul; 19(7):O263-O271. PubMed ID: 28603932
[TBL] [Abstract][Full Text] [Related]
3. Comparison of efficacy and safety of preoperative Chemoradiotherapy in locally advanced upper and middle/lower rectal cancer.
Huang MY; Lee HH; Tsai HL; Huang CW; Yeh YS; Ma CJ; Huang CM; Chen CY; Huang JJ; Wang JY
Radiat Oncol; 2018 Mar; 13(1):53. PubMed ID: 29587797
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant chemoradiotherapy might provide survival benefit in patients with stage IIIb/IIIc locally advanced rectal cancer: A retrospective single-institution study with propensity score-matched comparative analysis.
Sun XY; Cai SH; Xu L; Luo D; Qiu HZ; Wu B; Lin GL; Lu JY; Zhang GN; Xiao Y
Asia Pac J Clin Oncol; 2020 Jun; 16(3):142-149. PubMed ID: 32031326
[TBL] [Abstract][Full Text] [Related]
5. The prognostic impact of neoadjuvant chemoradiotherapy on lymph node sampling in patients with locally advanced rectal cancer.
Li Destri G; Maugeri A; Ramistella A; La Greca G; Conti P; Trombatore G; Vecchio GM; Magro GG; Barchitta M; Agodi A
Updates Surg; 2020 Sep; 72(3):793-800. PubMed ID: 32632764
[TBL] [Abstract][Full Text] [Related]
6. Predictors of pathological complete response following neoadjuvant chemoradiotherapy for rectal cancer.
Mehraj A; Baba AA; Khan B; Khan MA; Wani RA; Parray FQ; Chowdri NA
J Cancer Res Ther; 2022 Dec; 18(Supplement):S391-S396. PubMed ID: 36510993
[TBL] [Abstract][Full Text] [Related]
7. Predicting the pathologic response of locally advanced rectal cancer to neoadjuvant concurrent chemoradiation using enzyme-linked immunosorbent assays (ELISAs) for biomarkers.
Yoon HI; Koom WS; Kim YB; Min BS; Lee KY; Kim NK; Shin SJ; Ahn JB; Keum KC
J Cancer Res Clin Oncol; 2014 Mar; 140(3):399-409. PubMed ID: 24390211
[TBL] [Abstract][Full Text] [Related]
8. Timing of surgery following neoadjuvant chemoradiotherapy in locally advanced rectal cancer - A comparison of magnetic resonance imaging at two time points and histopathological responses.
West MA; Dimitrov BD; Moyses HE; Kemp GJ; Loughney L; White D; Grocott MP; Jack S; Brown G
Eur J Surg Oncol; 2016 Sep; 42(9):1350-8. PubMed ID: 27160356
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of platelet-associated biomarkers in rectal cancer patients received neoadjuvant chemoradiation: A retrospective study.
Wang P; Wang Z; Liu Y; Xie J; Ren Y
Cancer Radiother; 2021 Apr; 25(2):147-154. PubMed ID: 33423969
[TBL] [Abstract][Full Text] [Related]
10. Treatment Utilization and Outcomes for Locally Advanced Rectal Cancer in Older Patients.
Nassoiy S; Christopher W; Marcus R; Keller J; Weiss J; Chang SC; Foshag L; Essner R; Fischer T; Goldfarb M
JAMA Surg; 2022 Nov; 157(11):e224456. PubMed ID: 36169964
[TBL] [Abstract][Full Text] [Related]
11. Concomitant Use of Proton Pump Inhibitors With Capecitabine Based Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: Is it Safe?
Menon A; Abraham AG; Mahfouz M; Thachuthara JJ; Usmani N; Warkentin H; Ghosh S; Nijjar T; Severin D; Tankel K; Paulson K; Mulder K; Roa W; Joseph K
Am J Clin Oncol; 2021 Sep; 44(9):487-494. PubMed ID: 34269694
[TBL] [Abstract][Full Text] [Related]
12. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
[No Abstract] [Full Text] [Related]
13. The potential benefit of adjuvant chemotherapy in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy is not predicted by tumor regression grade.
Bohlok A; Hendlisz A; Bouazza F; Galdon MG; Van de Stadt J; Moretti L; El Nakadi I; Liberale G
Int J Colorectal Dis; 2018 Oct; 33(10):1383-1391. PubMed ID: 29984385
[TBL] [Abstract][Full Text] [Related]
14. A multicentre cohort study assessing the utility of routine blood tests as adjuncts to identify complete responders in rectal cancer following neoadjuvant chemoradiotherapy.
Eastern Rectal Cancer Response Collaborative, Ireland
Int J Colorectal Dis; 2022 Apr; 37(4):957-965. PubMed ID: 35325271
[TBL] [Abstract][Full Text] [Related]
15. Muscle wasting and survival following pre-operative chemoradiotherapy for locally advanced rectal carcinoma.
Levolger S; van Vledder MG; Alberda WJ; Verhoef C; de Bruin RWF; IJzermans JNM; Burger JW
Clin Nutr; 2018 Oct; 37(5):1728-1735. PubMed ID: 28756039
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
Lin H; Wang L; Zhong X; Zhang X; Shao L; Wu J
World J Surg Oncol; 2021 May; 19(1):141. PubMed ID: 33952287
[TBL] [Abstract][Full Text] [Related]
17. Exercise prehabilitation may lead to augmented tumor regression following neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
West MA; Astin R; Moyses HE; Cave J; White D; Levett DZH; Bates A; Brown G; Grocott MPW; Jack S
Acta Oncol; 2019 May; 58(5):588-595. PubMed ID: 30724668
[TBL] [Abstract][Full Text] [Related]
18. The effects of neoadjuvant chemoradiotherapy on physical fitness and morbidity in rectal cancer surgery patients.
West MA; Loughney L; Barben CP; Sripadam R; Kemp GJ; Grocott MP; Jack S
Eur J Surg Oncol; 2014 Nov; 40(11):1421-8. PubMed ID: 24784775
[TBL] [Abstract][Full Text] [Related]
19. A study of inflammation-based predictors of tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
Krauthamer M; Rouvinov K; Ariad S; Man S; Walfish S; Pinsk I; Sztarker I; Charkovsky T; Lavrenkov K
Oncology; 2013; 85(1):27-32. PubMed ID: 23816828
[TBL] [Abstract][Full Text] [Related]
20. Systemic Immune-inflammation Index (SII) Predicts Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
Eraslan E; Adas YG; Yildiz F; Gulesen AI; Karacin C; Arslan UY
J Coll Physicians Surg Pak; 2021 Apr; 31(4):399-404. PubMed ID: 33866724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
